학술논문

Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial
Document Type
Article
Author
Sebok, AgnesPestronk, AlanDominovic-Kovacevic, AleksandraKhan, AnealKoritnik, BlažTard, CelineLindberg, ChristopherQuinn, ColinKornblum, CorneliaEldridge, CrystalBodkin, CynthiaReyes-Leiva, DavidHughes, DerralynnStefanescu, ElaSALORT-CAMPANA, EmmanuelleButler, ErnestBouhour, FrancoiseKim, GeeKonstantinos Papadimas, GeorgeParenti, GiancarloBartosik-Psujek, HalinaKushlaf, HaniAkihiro, HashiguchiLau, HeatherPedro, HelioAndersen, HenningAmartino, HernanShiraishi, HideakiKobayashi, HiroshiTarnev, IvayloVengoechea, JaimeAvelar, JenniferShin, Jin-HongCauci, JonathanAlonso-Pérez, JorgeJanszky, JozsefBerthy, JulieGutschmidt, KristinaClaeys, KristlJudit Molnar, MariaWencel, MarieTarnopolsky, MarkDimachkie, MazenTchan, MichelFreimer, MiriamLongo, NicolaVidal-Fernandez, NuriaMusumeci, OlimpiaGoker-Alpan, OzlemDeegan, PatrickClemens, Paula R.Roxburgh, RichardHenderson, RobertHopkin, RobertSacconi, SabrinaFecarotta, SimonaAttarian, ShahramWenninger, StephanDearmey, StephanieHiwot, TarekegnBurrow, ThomasRuck, TobiasSawada, TomoLaszlo, VesceiLöscher, WolfgangChien, Yin-HsiuSchoser, BenediktRoberts, MarkByrne, Barry JSitaraman, SheelaJiang, HaiLaforêt, PascalToscano, AntonioCastelli, JeffDíaz-Manera, JordiGoldman, Mitchellvan der Ploeg, Ans TBratkovic, DragoKuchipudi, SrilakshmiMozaffar, TahseenKishnani, Priya S
Source
In The Lancet Neurology December 2021 20(12):1027-1037
Subject
Primary Research
Articles
Language
ISSN
1474-4422